Category: Gastroenterology and Hepatology

  • UNC@DDW 2019

    UNC Gastroenterology travels to San Diego, CA on May 18-21 to give over one hundred and twenty presentations at this year’s Digestive Disease Week (DDW). DDW is the world’s largest gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy, and gastrointestinal surgery, and showcases the best and most innovative research in the field of gastr … Continued

  • Facing the Risk Empowered: Genetic Counseling and Surveillance for Gastrointestinal Cancer

    Genetic testing can provide peace of mind, empower patients to take a proactive approach to their health, and it can save lives. UNC’s High-Risk Gastrointestinal Cancer Clinic serves patients and families with a family history of gastrointestinal cancer and those affected by hereditary gastrointestinal cancer syndromes. Lacey Lee came to UNC to make informed decisions about her f … Continued

  • Joanna Herath

    Featured Administrator: Joanna Herath in the Division of Gastroenterology and Hepatology

    Administrators in the department of medicine ensure that division operations are managed efficiently and effectively, to support faculty, staff, and trainees in their pursuit of education, research and clinical care. Their services focus on achieving continuous improvement in the quality and the value of our work, for those we support and the patients we serve.

  • Michael W. Fried, MD

    Fried receives FDA Award for Regulatory Science Excellence

    Unique research network is recognized for providing a robust platform that curates real-world data for FDA scientists, helping them communicate the safety and effectiveness of direct-acting antiviral agents in the post-marketing period.

  • Michael W. Fried, MD

    Fried Receives FDA Award for Regulatory Science Excellence

    Unique research network is recognized for providing a robust platform that curates real-world data for FDA scientists, helping them communicate the safety and effectiveness of direct-acting antiviral agents in the post-marketing period.

  • Balfour Sartor, MD

    Sartor Named Crohn’s Disease Health Care Hero

    The National Liberty Museum honored Balfour Sartor, MD, with its inaugural Healthcare Hero in the Field of Crohn’s Disease for his decades of work to find better treatments for inflammatory bowel diseases. Balfour Sartor, MD R. Baltour Sartor, MD, the Midget Distinguished Professor of Medicine and Microbiology and Immunology, received the inaugural Healthcare Hero in the Field of … Continued

  • Balfour Sartor, MD

    Sartor Named Crohn’s Disease Health Care Hero

    The National Liberty Museum honored Balfour Sartor, MD, with its inaugural Healthcare Hero in the Field of Crohn’s Disease for his decades of work to find better treatments for inflammatory bowel diseases.

  • Dr. Anne Peery (Credit: Brian Strickland)

    Wall Street Journal Features Gastroenterology’s Dr. Anne Peery

    A new Wall Street Journal article tells how gastroenterologists are rethinking the cause and the treatment of diverticular disease.

  • L-R: Shehzad Z. Sheikh, MD, PhD and Terry Furey, PhD

    Genomic Study Finds New Role for MicroRNAs As Predictors of Crohn’s Disease Progression

    These findings by UNC School of Medicine researchers are an important step forward in designing more effective clinical trials and developing personalized Crohn’s disease therapies.

  • William E. Whitehead, PhD, principal investigator of NIH-funded fecal incontinence study

    Fecal incontinence study compares treatment efficiency, safety and cost

    The UNC School of Medicine is one of four clinical sites participating in a five-year $10 million NIH-funded project to identify the most effective treatment options for fecal incontinence. William E. Whitehead, PhD, professor of medicine in the department of medicine’s division of gastroenterology, is one of four principal investigators.